Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A polycystic ovary syndrome technology, applied in the direction of drug combination, pharmaceutical formula, plant raw materials, etc., can solve the problems of gonadotropin reduction, ovarian sex hormone synthesis and other problems
Inactive Publication Date: 2015-10-14
林加五
View PDF1 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0015] (5) Gonadotropin-releasing hormone (GnRH) GnRH can promote the release of FSH and LH from the pituitary gland, but long-term application can desensitize the G
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
specific Embodiment 1
[0055] Weigh: 9 grams of Cistanche; 30 grams of Curculigo, 6 grams of Curcuma, 8 grams of Atractylodes Rhizoma, 6 grams of Daphne Flower, 5 grams of Cinnamon, and 9 grams of Motherwort; add 8 times the amount of water, decoct for 1.5 hours, filter; 6 times the amount of water, decoct for 1 hour, filter; combine the filtrates, concentrate to 120 grams, and obtain a decoction that meets the daily dosage of normal adults.
[0056] For the treatment of polycystic ovary syndrome. Take it orally, and take it three times a day in the morning, afternoon and evening.
specific Embodiment 2
[0057] Weigh: 9 grams of Cistanche; 30 grams of Curculigo, 6 grams of Curcuma, 8 grams of Atractylodes Rhizoma, 6 grams of Daphne Flower, 5 grams of Cinnamon, and 9 grams of Motherwort; add 10 times the amount of water, decoct for 2 hours, filter; Take 8 times the amount of water, decoct for 1.5 hours, filter; combine the filtrates, concentrate, dry, and pack to obtain a powder that meets the daily dosage of normal adults.
[0058] For the treatment of polycystic ovary syndrome. Take it orally, once a day.
specific Embodiment 3
[0059] Weighing: 9 grams of Cistanche; 30 grams of curculi, 6 grams of turmeric, 8 grams of Atractylodes macrocephala, 6 grams of daphne flower, 5 grams of cinnamon, and 9 grams of motherwort; add 6 times the amount of water, decoct 3 times, each decoction After 1 hour, the decoction liquid is combined, concentrated, dried, and packed into a capsule shell to obtain a capsule that meets the daily dosage of a normal adult.
[0060] For the treatment of polycystic ovary syndrome. Take it orally, take it twice a day in the morning and evening.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a drug for treating polycystic ovarian syndrome. The drug is prepared from 9 parts by weight of cistanche, 30 parts by weight of Curculigo orchioides, 6 parts by weight of curcuma tuber, 8 parts by weight of bighead atractylodes rhizome, 6 parts by weight of Daphne odora Thumb., 5 parts by weight of cassia bark and 9 parts by weight of motherwort. Cistanche has effects of tonifying kidney and yang and boosting essence and blood. Curculigo orchioides has effects of invigorating spleen and kidney. Curcuma tuber has effects of acting liver and heart meridians, clearing away the heart-fire and relieving depression. Bighead atractylodes rhizome has effects of invigorating spleen and tonifying qi. Daphne odora Thumb. has effects of invigorating the circulation of blood and removing stasis. Cassia bark has effects of tonifying fire and helping yang, igniting to return a source, and warming meridians and dredging channels. Motherwort has effects of invigorating blood circulation and regulating menstruation. Through synergism of the above drugs, the drug has effects of tonifying kidney and supporting yang, invigorating spleen and resolving depression, and invigorating blood circulation and regulating menstruation and can treat polycystic ovarian syndrome.
Description
technical field [0001] The invention relates to a traditional Chinese medicine, in particular to a medicine for treating polycystic ovary syndrome. Background technique [0002] Polycystic ovary syndrome (PCOS) is a syndrome of endocrine disorders characterized by rare ovulation or anovulation, hyperandrogen or insulin resistance, and polycystic ovaries. Symptoms include oligomenorrhea or amenorrhea, chronic anovulation, infertility, hirsutism and acne. Due to continuous anovulation, in severe cases, the endometrium will hyperplasia and increase the risk of endometrial cancer. [0003] Clinical manifestations: 1. Abnormal menstruation: oligomenorrhea, amenorrhea, and a few can be manifested as functional uterine bleeding. Occurs mostly in puberty, irregular menstruation after menarche. 2. Hirsutism: more common, the incidence rate can reach 69%. Due to the increase of androgen, it can be seen that the vellus hair on the upper lip, mandible, chest, back, middle part of th...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more